Drugs / Hibiscus Sabdariffa
Hibiscus Sabdariffa
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT01414374 | Jan → Dec 2012 | iron deficiency anemia | Casa Espirita Terra de Ismael | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT06413550 | Apr 2024 → Jan 2025 | radiation-induced disorder | Ain Shams University | Unknown | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| — | NCT02216253 Comparator | Oct 2014 → Aug 2015 | pelvic organ prolapse, urinary tract infection | IRCCS San Raffaele | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hibiscus Sabdariffa | “Hibiscus sabdariffa (powdered dry plant), 200 mg, BID” NCT01414374 ↗ |
| Known as | Hibiscus Sabdariffa L. | “The Efficacy of Hibiscus Sabdariffa L. Mouth Rinse in Head and Neck Cancer Patients With Xerostomia: A Randomized, Placebo-Controlled Clinical Trial” NCT06413550 ↗ |
| Known as | karkadé | “Aqualief contains two key ingredients, carnosine and karkadé (Hibiscus sabdariffa), which were selected and mixed with normalizing saliva pH and increasing saliva buffering activity.” NCT06413550 ↗ |
| Known as | Roselle | “The fresh red Roselle plant was obtained; the red calyxes of Hibiscus Sabdariffa were separated from the plant and dried for a week at 25°C.” NCT06413550 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “a composite herbal medicine (Hibiscus sabdariffa plus Centella asiatica)” NCT01414374 ↗ |
| Route | Oral | “as oral rinse” NCT06413550 ↗ |